Summary Wakamoto Pharmaceutical Co Ltd (Wakamoto) is a pharmaceutical company that manufactures and markets prescription drugs and pharmaceuticals. The company manufactures and sells ethical drugs and non-prescription drugs. Its wakamoto is a gastrointestinal drug containing yeast used for controlling intestinal function, digestion and nutritional supply. It provides products for the treatment of stomach disorders, anorexia, dyspepsia, a feeling of gastrointestinal and abdominal fullness due to dyspepsia, overeating, retching and digestion promotion. Wakamoto’s products provide nutritional boost, delicate constitution, and nutritional support for physical exhaustion, physical condition during and after illness, gastrointestinal disorder, nutrition disorder, pyretic and degenerative diseases, and physical condition before and after childbirth. The company operates through its branch offices, research laboratory, and plant located in Sapporo, Sendai, Kanto, Tokyo, Nagoya, Osaka, Hiroshima and Fukuoka, among others. Wakamoto is headquartered in Tokyo, Japan. Wakamoto Pharmaceutical Co Ltd (4512) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on... Research Beam Model: Research Beam Product ID: 1995637 250 USD New
Wakamoto Pharmaceutical Co Ltd (4512) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Wakamoto Pharmaceutical Co Ltd (4512) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : August   2017
  • Pages : 17
  • Publisher : GlobalData
 
 
 
Summary

Wakamoto Pharmaceutical Co Ltd (Wakamoto) is a pharmaceutical company that manufactures and markets prescription drugs and pharmaceuticals. The company manufactures and sells ethical drugs and non-prescription drugs. Its wakamoto is a gastrointestinal drug containing yeast used for controlling intestinal function, digestion and nutritional supply. It provides products for the treatment of stomach disorders, anorexia, dyspepsia, a feeling of gastrointestinal and abdominal fullness due to dyspepsia, overeating, retching and digestion promotion. Wakamoto’s products provide nutritional boost, delicate constitution, and nutritional support for physical exhaustion, physical condition during and after illness, gastrointestinal disorder, nutrition disorder, pyretic and degenerative diseases, and physical condition before and after childbirth. The company operates through its branch offices, research laboratory, and plant located in Sapporo, Sendai, Kanto, Tokyo, Nagoya, Osaka, Hiroshima and Fukuoka, among others. Wakamoto is headquartered in Tokyo, Japan.

Wakamoto Pharmaceutical Co Ltd (4512) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bausch & Lomb Japan Enters Into Co-Marketing Agreement With Wakamoto Pharma 10
Licensing Agreements 11
Wakamoto Pharma Enters into Licensing Agreement with D. Western Therapeutics Institute 11
Ab-Biotics Enters into Option for Licensing Agreement with Wakamoto Pharma 12
Wakamoto Pharmaceutical Co Ltd - Key Competitors 13
Wakamoto Pharmaceutical Co Ltd - Key Employees 14
Wakamoto Pharmaceutical Co Ltd - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Wakamoto Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bausch & Lomb Japan Enters Into Co-Marketing Agreement With Wakamoto Pharma 10
Wakamoto Pharma Enters into Licensing Agreement with D. Western Therapeutics Institute 11
Ab-Biotics Enters into Option for Licensing Agreement with Wakamoto Pharma 12
Wakamoto Pharmaceutical Co Ltd, Key Competitors 13
Wakamoto Pharmaceutical Co Ltd, Key Employees 14
Wakamoto Pharmaceutical Co Ltd, Other Locations 15
List of Figures
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Wakamoto Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter